0001127602-22-019146.txt : 20220708
0001127602-22-019146.hdr.sgml : 20220708
20220708163926
ACCESSION NUMBER: 0001127602-22-019146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220706
FILED AS OF DATE: 20220708
DATE AS OF CHANGE: 20220708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoffman William
CENTRAL INDEX KEY: 0001304099
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 221074834
MAIL ADDRESS:
STREET 1: C/O INARI MEDICAL, INC.
STREET 2: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-07-06
0001531048
Inari Medical, Inc.
NARI
0001304099
Hoffman William
C/O INARI MEDICAL, INC.
6001 OAK CANYON
IRVINE
CA
92618
1
1
President and CEO
Common Stock
2022-07-06
4
M
0
30000
.4284
A
578899
D
Common Stock
2022-07-06
4
S
0
20077
71.73
D
558822
D
Common Stock
2022-07-06
4
S
0
9123
72.44
D
549699
D
Common Stock
2022-07-06
4
S
0
800
73.34
D
548899
D
Common Stock
2022-07-07
4
S
0
13488
75.08
D
535411
D
Stock Option
.4284
2022-07-06
4
M
0
30000
0
D
2028-12-13
Common Stock
30000
290168
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2021.
This transaction was executed in multiple trades at prices ranging from $71.14 to $72.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $72.14 to $73.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $73.26 to $73.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $75.00 to $75.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option is vested and exercisable as to 133,231 shares, and the remaining shares will vest and become exercisable in equal monthly installments until December 13, 2022.
/s/ Angela Ahmad, attorney-in-fact for William Hoffman
2022-07-08